Home

Medtronic (MDT)

90.97
0.00 (0.00%)

Medtronic is a global leader in medical technology, focused on developing and providing innovative therapeutic solutions to improve the lives of patients

The company specializes in a wide range of medical devices and therapies, addressing conditions in areas such as diabetes care, cardiovascular health, surgical innovations, and neurological disorders. Medtronic is committed to advancing healthcare through cutting-edge research, collaboration with healthcare providers, and a strong emphasis on patient-centered care, aiming to enhance the quality of life for millions around the world.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close90.97
Open-
Bid90.39
Ask91.52
Day's RangeN/A - N/A
52 Week Range75.96 - 93.08
Volume823
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield2.800 (3.08%)
1 Month Average Volume7,752,247

News & Press Releases

Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbasebenzinga.com
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSEABBV), saying it's “just a gem” and a “winner.”  He added, “I can't believe the stock dropped so much.”
Via Benzinga · February 5, 2025
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
NEW HOPE, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the appointment of Christopher Cleary to its Board of Directors as an independent member, effective as of January 30, 2025. Mr. Cleary brings over three decades of experience in corporate development, mergers, acquisitions, strategic investments and structured R&D collaborations, having significantly impacted the medical technology industry through his strategic leadership and visionary approach.
By Orchestra BioMed Holdings, Inc. · Via GlobeNewswire · February 5, 2025
3 Top Dividend Stocks I Plan to Buy in My Retirement Account in Februaryfool.com
Via The Motley Fool · February 1, 2025
The Smartest Dividend Stocks to Buy With $100 Right Nowfool.com
Via The Motley Fool · January 30, 2025
Is Medtronic's Dividend Safe?fool.com
Via The Motley Fool · January 8, 2025
1 Growth Stock Down 6% to Buy Right Nowfool.com
Via The Motley Fool · January 8, 2025
Looking Into Medtronic's Recent Short Interestbenzinga.com
Via Benzinga · December 24, 2024
Neurotech Reports Announces First European Leaders Forum
SAN FRANCISCO, Calif., Jan. 30, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the longest-serving publishing and market intelligence firm covering the neuromodulation industry, announced the launch of its first European management and investment conference. The two-day event, called Neurotech Leaders Forum at imec, will take place on June 3-4, 2025 on the campus of imec in Leuven, Belgium. Imec, a world-leading research and innovation center in nanoelectronics and digital technologies, is deeply committed to advancing health innovations through the power of semiconductor technologies, making it the ideal host for the conference. - News from Neurotech Reports, issued by Send2Press Newswire
Via Send2Press · January 30, 2025
3 Reasons to Buy Medtronic Stock Like There's No Tomorrowfool.com
This medtech giant is leveraging the power of artificial intelligence for a strong growth outlook.
Via The Motley Fool · January 28, 2025
9 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · January 28, 2025
1 Top Dividend Stock to Buy in 2025, and 1 to Avoidfool.com
Via The Motley Fool · January 25, 2025
Here's How Many Shares of Medtronic You Need to Own to Get $1,000 in Yearly Dividendsfool.com
Via The Motley Fool · January 25, 2025
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Foreverfool.com
Via The Motley Fool · January 21, 2025
Intuitive Surgical Leads the Pack in Robotic Surgery Innovation
The robotic-assisted surgery trend is accelerating and Intuitive Surgical continues to lead the pack as its continued to keeps its wide moat since 2000.
Via MarketBeat · January 21, 2025
How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQTEM),NYSE:MDTNYSEMDT)(NYSE:TDOCNYSETDOC,(NASDAQ:TALKNASDAQ) EQNX::TICKER_END
Via FinancialNewsMedia · January 16, 2025
3 Incredible Dividend Stocks to Buy in 2025fool.com
These wildly successful companies are poised to keep your dividend portfolio healthy in 2025 and beyond.
Via The Motley Fool · January 11, 2025
2 MedTech Stocks That Are Screaming Buys in Januaryfool.com
Via The Motley Fool · January 10, 2025
J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Productinvestors.com
The company paused sales of a key product, a rival to Boston Scientific and Medtronic, due to safety concerns.
Via Investor's Business Daily · January 8, 2025
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analystbenzinga.com
Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR by 2030.
Via Benzinga · January 7, 2025
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decadefool.com
Via The Motley Fool · January 4, 2025
3 Stocks Helping to Bring AI to Healthcare
Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends
Via MarketBeat · December 31, 2024
3 Dividend Stocks to Double Up on Right Nowfool.com
If you are an avid dividend investor, here are three attractive dividend stocks you should accumulate now.
Via The Motley Fool · December 28, 2024
4 Dividend Stocks to Double Up on Right Nowfool.com
Via The Motley Fool · December 25, 2024
10 Best Stocks For Compounding Dividendstalkmarkets.com
High-quality dividend growth stocks can build long-term wealth for shareholders. A major reason for this is the combination of dividend growth and dividend reinvestment.
Via Talk Markets · December 19, 2024
Why Healthcare Providers Are Increasingly Trusting Artificial Intelligence for Detection & Diagnosis
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQTEM),NYSE:MDTNYSEMDT)(NYSE:SYKNYSESYK,(NASDAQ:PEGANASDAQ) EQNX::TICKER_END
Via FinancialNewsMedia · December 17, 2024